INS and gestational diabetes: Artificial intelligence (AI) has emerged as a transformative tool in modern medicine, offering new possibilities for predictive analytics, personalized interventions, and automated decision-making.14 In the field of GDM, AI-driven approaches, particularly machine learning (ML) and deep learning (DL) algorithms, have demonstrated promising capabilities in the early risk prediction, continuous glucose monitoring, insulin-dosing recommendations, and outcome prediction.